Galderma Presented Final Results from Phase 2b Study of Nemolizumab in Patients with Moderate-to-Severe Atopic Dermatitis at the 2019 American Academy of Dermatology...
West Virginia Business
•
Mar 8, 2019
Latest West Virginia stories tagged “Switzerland”.